OBJECTIVE: To examine the efficacy of exposure-based cognitive-behavioral therapy (CBT) plus a structured family intervention (FCBT) versus psychoeducation plus relaxation training (PRT) for reducing symptom severity, functional impairment, and family accommodation in youths with obsessive-compulsive disorder (OCD). METHOD: A total of 71 youngsters 8 to 17 years of age (mean 12.2 years; range, 8-17 years, 37% male, 78% Caucasian) with primary OCD were randomized (70:30) to 12 sessions over 14 weeks of FCBT or PRT. Blind raters assessed outcomes with responders followed for 6 months to assess treatment durability. RESULTS:FCBT led to significantly higher response rates than PRT in ITT (57.1% vs 27.3%) and completer analyses (68.3% vs. 35.3%). Using HLM, FCBT was associated with significantly greater change in OCD severity and child-reported functional impairment than PRT and marginally greater change in parent-reported accommodation of symptoms. These findings were confirmed in some, but not all, secondary analyses. Clinical remission rates were 42.5% for FCBT versus 17.6% for PRT. Reduction in family accommodation temporally preceded improvement in OCD for both groups and child functional status for FCBT only. Treatment gains were maintained at 6 months. CONCLUSIONS:FCBT is effective for reducing OCD severity and impairment. Importantly, treatment also reduced parent-reported involvement in symptoms with reduced accommodation preceding reduced symptom severity and functional impairment. CLINICAL TRIALS REGISTRY INFORMATION: Behavior Therapy for Children and Adolescents with Obsessive-Compulsive Disorder (OCD); http://www.clinicaltrials.gov; NCT00000386.
RCT Entities:
OBJECTIVE: To examine the efficacy of exposure-based cognitive-behavioral therapy (CBT) plus a structured family intervention (FCBT) versus psychoeducation plus relaxation training (PRT) for reducing symptom severity, functional impairment, and family accommodation in youths with obsessive-compulsive disorder (OCD). METHOD: A total of 71 youngsters 8 to 17 years of age (mean 12.2 years; range, 8-17 years, 37% male, 78% Caucasian) with primary OCD were randomized (70:30) to 12 sessions over 14 weeks of FCBT or PRT. Blind raters assessed outcomes with responders followed for 6 months to assess treatment durability. RESULTS:FCBT led to significantly higher response rates than PRT in ITT (57.1% vs 27.3%) and completer analyses (68.3% vs. 35.3%). Using HLM, FCBT was associated with significantly greater change in OCD severity and child-reported functional impairment than PRT and marginally greater change in parent-reported accommodation of symptoms. These findings were confirmed in some, but not all, secondary analyses. Clinical remission rates were 42.5% for FCBT versus 17.6% for PRT. Reduction in family accommodation temporally preceded improvement in OCD for both groups and child functional status for FCBT only. Treatment gains were maintained at 6 months. CONCLUSIONS:FCBT is effective for reducing OCD severity and impairment. Importantly, treatment also reduced parent-reported involvement in symptoms with reduced accommodation preceding reduced symptom severity and functional impairment. CLINICAL TRIALS REGISTRY INFORMATION: Behavior Therapy for Children and Adolescents with Obsessive-Compulsive Disorder (OCD); http://www.clinicaltrials.gov; NCT00000386.
Authors: Eric A Storch; Michael J Larson; Jordana Muroff; Nicole Caporino; Daniel Geller; Jeannette M Reid; Jessica Morgan; Patrice Jordan; Tanya K Murphy Journal: J Anxiety Disord Date: 2009-12-16
Authors: Jennifer B Freeman; Abbe M Garcia; Lisa Coyne; Chelsea Ale; Amy Przeworski; Michael Himle; Scott Compton; Henrietta L Leonard Journal: J Am Acad Child Adolesc Psychiatry Date: 2008-05 Impact factor: 8.829
Authors: Eric A Storch; Gary R Geffken; Lisa J Merlo; Marni L Jacob; Tanya K Murphy; Wayne K Goodman; Michael J Larson; Melanie Fernandez; Kristen Grabill Journal: J Clin Child Adolesc Psychol Date: 2007 Apr-Jun
Authors: Thomas H Ollendick; Lars-Göran Ost; Lena Reuterskiöld; Natalie Costa; Rio Cederlund; Cristian Sirbu; Thompson E Davis; Matthew A Jarrett Journal: J Consult Clin Psychol Date: 2009-06
Authors: Eric A Storch; Gary R Geffken; Lisa J Merlo; Giselle Mann; Danny Duke; Melissa Munson; Jennifer Adkins; Kristen M Grabill; Tanya K Murphy; Wayne K Goodman Journal: J Am Acad Child Adolesc Psychiatry Date: 2007-04 Impact factor: 8.829
Authors: Jason Gallant; Eric A Storch; Lisa J Merlo; Emily D Ricketts; Gary R Geffken; Wayne K Goodman; Tanya K Murphy Journal: J Anxiety Disord Date: 2008-02-07
Authors: Joseph O'Neill; John Piacentini; Susanna Chang; Ronald Ly; Tsz M Lai; Casey C Armstrong; Lindsey Bergman; Michelle Rozenman; Tara Peris; Allison Vreeland; Ross Mudgway; Jennifer G Levitt; Noriko Salamon; Stefan Posse; Gerhard S Hellemann; Jeffry R Alger; James T McCracken; Erika L Nurmi Journal: Neuropsychopharmacology Date: 2017-04-04 Impact factor: 7.853
Authors: James G Waxmonsky; Daniel A Waschbusch; Peter Belin; Tan Li; Lysett Babocsai; Hugh Humphery; Meaghan E Pariseau; Dara E Babinski; Martin T Hoffman; Jenifer L Haak; Jessica R Mazzant; Gregory A Fabiano; Jeremy W Pettit; Negar Fallahazad; William E Pelham Journal: J Am Acad Child Adolesc Psychiatry Date: 2015-12-28 Impact factor: 8.829
Authors: Mariela Rance; Christopher Walsh; Denis G Sukhodolsky; Brian Pittman; Maolin Qiu; Stephen A Kichuk; Suzanne Wasylink; William N Koller; Michael Bloch; Patricia Gruner; Dustin Scheinost; Christopher Pittenger; Michelle Hampson Journal: Neuroimage Date: 2018-05-02 Impact factor: 6.556
Authors: Tara S Peris; Scott N Compton; Philip C Kendall; Boris Birmaher; Joel Sherrill; John March; Elizabeth Gosch; Golda Ginsburg; Moira Rynn; James T McCracken; Courtney P Keeton; Dara Sakolsky; Cynthia Suveg; Sasha Aschenbrand; Daniel Almirall; Satish Iyengar; John T Walkup; Anne Marie Albano; John Piacentini Journal: J Consult Clin Psychol Date: 2014-12-08